Wildner Dane, Strobel Deike, Konturek Peter C, Görtz Rüdiger S, Croner Roland S, Neurath Markus F, Zopf Steffen
Department of Internal Medicine 1, University Hospital Erlangen, Erlangen, Germany.
Department of Internal Medicine II, Thüringen-Klinik, Saalfeld, Germany.
Med Sci Monit. 2014 Oct 24;20:2027-35. doi: 10.12659/MSM.891126.
Acoustic radiation force impulse (ARFI) elastography is a reliable diagnostic device for quantitative non-invasive assessment of liver fibrosis in patients with chronic liver disease. The aim of our prospective study was to evaluate the impact of ARFI in patients after orthotopic liver transplantation (OLT). Therefore, we compared ARFI shear wave velocities with clinical features, non-invasive markers, and the histology of patients following OLT.
Post-transplant patients underwent a clinical examination and blood samples were taken. B-mode and Doppler ultrasound (US) of the portal vein and the hepatic artery were performed. Subsequently, a minimum of 10 valid ARFI values were measured in the left and right liver lobe. Liver biopsy was performed if indicated.
Between May 2012 and May 2014, 58 Patients after OLT were included in the prospective study. Laboratory markers and aspartate aminotransferase-to-platelet ratio index (APRI) correlated with ARFI values (r=0.44, p<0.001). The histological (n=22) fibrosis score (Ludwig) was significantly correlated with the ARFI of the biopsy site (r=0.55, p=0.008). The mean shear-wave velocities were significantly increased in advanced fibrosis (F≤2 1.57±0.57 m/s; F≥3 2.85±0.66 m/s; p<0.001), obstructive cholestasis and active viral hepatitis. The area under the receiver operating characteristic (AUROC) curves for the accuracy of ARFI were 74% (F≥1), 73% (F≥2), 93% (F≥3), and 80% (=F4).
ARFI elastography correlates well with laboratory values and with noninvasive and invasive markers of fibrosis in patients after OLT. In this regard, elevated ARFI-velocities should be interpreted with caution in the context of obstructive cholestasis and active viral disease.
声辐射力脉冲(ARFI)弹性成像技术是一种用于对慢性肝病患者肝纤维化进行定量无创评估的可靠诊断设备。我们这项前瞻性研究的目的是评估ARFI在原位肝移植(OLT)患者中的作用。因此,我们比较了OLT术后患者的ARFI剪切波速度与临床特征、无创指标以及组织学情况。
对移植后患者进行临床检查并采集血样。对门静脉和肝动脉进行B超和多普勒超声(US)检查。随后,在左右肝叶测量至少10个有效的ARFI值。如有指征则进行肝活检。
在2012年5月至2014年5月期间,58例OLT术后患者被纳入这项前瞻性研究。实验室指标和天冬氨酸转氨酶与血小板比值指数(APRI)与ARFI值相关(r = 0.44,p < 0.001)。组织学(n = 22)纤维化评分(路德维希评分)与活检部位的ARFI显著相关(r = 0.55,p = 0.008)。在晚期纤维化(F≤2 1.57±0.57 m/s;F≥3 2.85±0.66 m/s;p < 0.001)、梗阻性胆汁淤积和活动性病毒性肝炎中,平均剪切波速度显著增加。ARFI准确性的受试者工作特征(AUROC)曲线下面积分别为74%(F≥1)、73%(F≥2)、93%(F≥3)和80%(=F4)。
ARFI弹性成像与OLT术后患者的实验室值以及纤维化的无创和有创指标相关性良好。在这方面,在梗阻性胆汁淤积和活动性病毒疾病的背景下,对升高的ARFI速度应谨慎解读。